跳到正文
cccskills
免费在 GitHub 公开

es-cushing-suggest-repeat-transsphenoidal-surgery

Suggests repeat transsphenoidal surgery for patients with persistent hypercortisolism after initial transsphenoidal surgery when imaging shows evidence of incomplete resection or a pituitary lesion. Clinical triggers include postoperative MRI revealing residual adenoma, persistent elevated UFC or late-night salivary cortisol, and visible pituitary lesion on imaging.

中文简介正在准备中。当前显示原文说明。

查看安装方法

包含的文件(1)

  • SKILL.md2.5 KB

SKILL.md(原文)

安装前可以查看交给 AI 代理的指令内容。

Suggest Repeat Transsphenoidal Surgery for Evidence of Incomplete Resection or Pituitary Lesion on Imaging

STEP 1 — Gather Information

Collect postoperative biochemical tests (UFC, late-night salivary cortisol, serum cortisol) and pituitary MRI performed 1–3 months after initial transsphenoidal surgery; document surgical report for extent of resection and any intraoperative findings.

STEP 2 — Rule In / Rule Out

Rule in persistent hypercortisolism if UFC or late-night salivary cortisol remains above the upper limit of normal on two occasions; rule out transient hypercortisolism due to stress or medication by confirming biochemical persistence and excluding exogenous glucocorticoid use.

STEP 3 — Classify or Stratify

Classify as candidate for repeat transsphenoidal surgery if MRI shows a residual pituitary lesion or evidence of incomplete resection (e.g., residual adenoma, enhancing lesion in sella) and the patient is a suitable surgical candidate; otherwise consider alternative second-line therapies.

STEP 4 — Decide

If criteria are met, refer to an experienced pituitary surgeon for evaluation and schedule repeat transsphenoidal surgery; if not, initiate medical therapy or consider radiotherapy based on patient preference and tumor characteristics.

Clinical Guardrails / Mimics / Pitfalls

Do not repeat surgery without clear biochemical evidence of persistent disease and imaging correlate; avoid surgery in patients with high surgical risk or uncontrolled comorbidities; be aware that postoperative MRI can show postoperative changes mimicking residual tumor, so correlate with clinical and biochemical data.

Concrete Clinical Example

A 42‑year‑old woman undergoes transsphenoidal surgery for Cushing’s disease; postoperative MRI at 8 weeks shows a 4 mm enhancing lesion in the sella and UFC remains 2× ULN; she is referred for repeat transsphenoidal surgery, which achieves biochemical remission.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2015, DOI:10.1210/jc.2015-1818

评价

还没有评价。欢迎分享你的使用感受。

评论

无需登录即可发表。欢迎分享使用感受、提问,或说明在哪些环境下无法运行。

还没有评论。来写第一条吧。

提交后会立即公开。请勿填写邮箱、电话等个人信息。URL 最多 2 个。

0 / 1000 字

此表单受 reCAPTCHA 保护,适用 Google 的隐私权政策和服务条款。

同一仓库的技能

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

查看 dromlakhani 的全部技能

报告此技能的问题